Dobrzelecki Legacy Ventures

Dobrzelecki Legacy Ventures is an early-stage venture capital firm that invests in healthcare technology and life sciences startups operating from a currently undisclosed geographic location. The organization primarily focuses on providing seed capital to emerging companies developing innovative solutions in assistive technology and physical rehabilitation. In October 2025, the firm notably led a $3 million seed funding round for Assistive Technology Development, Inc. (ATDev), an enterprise building artificial intelligence-powered rehabilitation exoskeletons. During this transaction, the investment vehicle syndicated its capital deployment alongside prominent co-investors including Uphonest Capital and The Life Science Angels. While the firm maintains an active presence in early-stage life sciences venture capital, specific metrics regarding its total assets under management remain private. The founding year and the identities of the original founders of Dobrzelecki Legacy Ventures are currently undisclosed in public records.